scope:

The NAVLERB will serve as an advisory board to the Chief, Bureau of Medicine and Surgery (BUMED), thus informing, drafting, and recommending policy for Budget Submitting Organization 18 medical laboratory equipment within Navy Medicine. The NAVLERB will be the Navy Medicine agent for the evaluation of medical laboratory equipment. All individual or group medical laboratory equipment acquisitions with a value of $3,000 or more, all cost per test/reportable contracts, equipment leases, interfacility test transfers, reference laboratory contracts, and medical laboratory equipment maintenance for Navy Medicine will be reviewed by the NAVLERB to ensure standardization and quality are in line with strategic and operational objectives. The NAVLERB is the appointed representative of the Chief, BUMED when called upon or directed to participate in Office of the Assistant Secretary of Defense (Health Affairs) and quad-service forums that evaluate and assess technology, coordinate policy development, technology implementation, and acquisition issues.

Purpose.

To establish a Naval Laboratory Equipment Review Board (NAVLERB) within the naval service to evaluate new and emerging medical laboratory technologies. To recommend short and long range planning, policy, governance, and acquisition strategies for laboratory equipment, and related support equipment, including military construction (MILCON) projects.

a. Medical laboratory equipment types include, but are not limited to the following: chemistry, hematology, urinalysis, microbiology, blood bank, histology, cytology, and esoteric testing. This instruction does not apply to research laboratory equipment.

b. If uncertainty regarding equipment that qualifies as medical laboratory equipment types arises, contact Naval Medical Logistics Command (NAVMEDLOGCOM), Expense Equipment Program Manager, (301) 619-3083,